Search
Selected EMA news
Most of EHA’s regulatory activities focus on collaboration with the European Medicines Agency (EMA).
Read morePublications
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Read moreTargeting the B-cell Receptor in Aggressive B-cell Lymphomas
In collaboration with Dr. Lou Staudt, Pharmacyclics and associate investigators, we performed a clinical trial of a very potent inhibitor of Bruton Tyrosine Kinase (BTK) called ibrutinib.
Read moreEHA-ISHBT Hematology Tutorial on Lymphoproliferative and Plasma Cell Disorders
EHA Hematology Tutorial in collaboration with the Indian Society of Hematology & Blood Transfusion
Dates: February 16-18, 2018
Location: Lucknow, India
Chairs: AK Tripathi & G Gaidano
Goal of the meeting
This three day event aims to increase the knowledge of participants on how to provide…
EHA-HKSH Hematology Tutorial
EHA is joining the Hong Kong Society of Hematology (HKSH) to organize the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies.
Read moreEHA-HKSH Hematology Tutorial on Lymphoid Malignancies
Dates: April 25-26, 2020
Location: Hong Kong
Chairs: G Gaidano, J Gribben, MF Law
In 2020 EHA will co-organize the first Hematology Tutorial in Hong Kong, together with the Hong Kong Society of Haematology (HKSH).
SWG Educational Activities
Social and public activitiesSince 2020, Prof Hermann Einsele has been a Councilor to the EHA Board. Scientific activitiesFifth European CAR T-cell meetingDateFebruary 9–11, 2023. LocationRotterdam, The Netherlands.
Read moreSWG Educational Activities
MeetingsEHA SWG EWALL SymposiumLocation and dateThis meeting was held in Frankfurt in June 2023 as part of EHA2023. TopicPersonalized ALL therapy. ChairNicola Gokbuget
Sessions and speakers
B-cell precursor ALL, the Finnish experience (Kimmo Porkka).